Summary:
- The 2024 Lasker Award, one of the most prestigious prizes in biomedical research, has been awarded to three scientists who made key contributions to the discovery and development of GLP-1 agonists, a class of drugs used to treat type 2 diabetes and obesity.
- The recipients are Svetlana Mojsov, Joel Habener, and Jens Knudsen, whose pioneering work in the 1970s and 1980s laid the foundation for the development of GLP-1 agonists, which have become a widely used and effective treatment for these conditions.
- The award highlights the importance of fundamental scientific research in advancing medical treatments and the impact that the discovery of GLP-1 has had on improving the lives of millions of people with type 2 diabetes and obesity.